Key facts
- CRISM Therapeutics received a £99,902 grant.
- The grant will advance the company's cancer program.
- Funding will support the development of novel cancer therapeutic strategies.
This grant provides CRISM Therapeutics with crucial funding to accelerate the development of its cancer therapies. Such funding is vital for early-stage biotech companies to progress their research and bring potential new treatments to market.